PathAI’s Post

Our Chief Medical Officer, Eric Walk MD, FCAP, presented on behalf of PathAI at the #AWSSummit this week in NYC. Dr. Walk shared insights into how PathAI is leveraging cloud infrastructure to unlock the next wave of #precisionmedicine innovation. Using examples from our cutting-edge AISight® image management system and platform, he highlighted the transformative power of #digitalpathology and #AI. At PathAI, we believe the future of patient care will be revolutionized by digital pathology and artificial intelligence, driving better patient outcomes, enhanced diagnostic accuracy, and operational efficiency. Check out some highlights from his presentation and see how PathAI is leading the way in AI-driven and digital diagnostics. Link https://lnkd.in/eR8dWEWu #PathAI #AWSsummit #PrecisionMedicine #DigitalPathology #AI #HealthcareInnovation #Diagnostics #Healthcare #Pathology AISight® is for research use only. Not for use in diagnostic procedures.

🔎 Interested in analyzing the tissue microenvironment in inflammatory bowel disease? View #IBD #pathology samples through the enhanced lens of #AI with IBD Explore™! You can now access our new IBD Explore™ demo to see how #AI-powered digital pathology can supercharge your #digestivedisease research. IBD Explore™ enables a detailed quantification of tissue regions, cellular composition, and inflammatory infiltration in H&E-stained #UC and #CD biopsies. Human-interpretable features from IBD Explore™ can be used to explore tissue composition, quantify treatment effect and mechanism of action, or identify possible #biomarkers predictive of drug response. Sign up for an account to access our demo; if you've already registered an account, the new slides are already available! https://lnkd.in/eCn4xwj2 #pathology #IBD #AI #digitalpathology #precisionmedicine IBD Explore™ is for research use only. Not for use in diagnostic procedures.

🗞 We're thrilled to announce the launch of our new quarterly newsletter, designed to keep you at the forefront of AI-powered #pathology advancements. Stay up to date with the latest PathAI #digitalpathology innovations, announcements, publications, and more. Whether you're a pathologist, researcher, or simply passionate about the future of #medicine, our newsletter is your gateway to understanding how AI is revolutionizing pathology. Sign up: https://lnkd.in/ezFEqmeK #AI #biotech #MachineLearning #DeepLearning #Oncology #biotechnology

🎆 Happy Independence Day from all of us at PathAI! 🎆 As we celebrate the 4th of July, we reflect on the freedoms we enjoy individually and as a collective, and how they enable the work we do. Thank you for partnering with us to innovate #pathology.

This past week, we published our article, 𝐀𝐈 𝐩𝐨𝐰𝐞𝐫𝐞𝐝 𝐪𝐮𝐚𝐧𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐧𝐮𝐜𝐥𝐞𝐚𝐫 𝐦𝐨𝐫𝐩𝐡𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐜𝐚𝐧𝐜𝐞𝐫𝐬 𝐞𝐧𝐚𝐛𝐥𝐞𝐬 𝐩𝐫𝐞𝐝𝐢𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐠𝐞𝐧𝐨𝐦𝐞 𝐢𝐧𝐬𝐭𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐩𝐫𝐨𝐠𝐧𝐨𝐬𝐢𝐬, in npj Precision Oncology where we describe the development of of a pan-tissue, #deeplearning based digital pathology pipeline for nucleus detection, segmentation, and classification enhancing nuclear morphologic #biomarker discovery. https://lnkd.in/eJwF_YZH Did you know that quantification of nuclear morphology is available as part of the PathExplore™ suite of algorithms? Here it is in action! Dive deep into nuclear morphology, cell & tissue segmentation, and more with PathExplore™ for #cancerresearch. Access our demo slides on our AISight® TxR platform so you can see all of the capabilities of AI-powered pathology has to offer: https://lnkd.in/eCn4xwj2 PathExplore™ is for research use only. Not for use in diagnostic procedures. #pathology #biotech #AI #biotechnology #oncology

Our recent manuscript published in 𝐧𝐩𝐣 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐎𝐧𝐜𝐨𝐥𝐨𝐠𝐲 details the development of our pan-tissue, AI-powered #digitalpathology pipeline for segmentation, identification, and classification of nuclear features directly from H&E whole-slide images. https://lnkd.in/eJwF_YZH A team of PathAI scientists led by John Abel utilized #deeplearning and trained PathExplore™ to dive deep into tumor biology, characterizing cell nuclei to help pathologists identify novel biomarkers, examine the relationship between nuclear morphology and genetic factors, and advance research into oncogenic transformation. Read more about the nuclear morphology and how researchers can utilize the PathExplore™ platform to expedite insights into #cancer biology, detection, and progression. #biotech #biotechnology #AI #pathology #oncology #deeplearning #machinelearning #cancerresearch PathExplore™ is for research use only. Not for use in diagnostic procedures.

We’re hiring! Our team is passionate about solving big challenges in #healthtech and transforming the field of #pathology with #artificialintelligence. We are looking for new team members to join us on our mission to improve patient outcomes & fuel #biopharma research. Our core values: -𝐏atients First We embody a patient first mindset with everything we do and are committed to meeting the needs of our customers to improve patient outcomes. -𝐀ccountability We set out to accomplish the tasks we commit to and take responsibility for our work, and our actions. -𝐓eam We are One PathAI, all working towards the same goal. We trust our teammates and count on each other to get the job done. -𝐇umility We know all that we do matters, big and small. We value openness, we are accepting of others, and are curious to learn from each other. -𝐀ll 𝐈n We are all passionate about our mission and our passion pushes us to be better every day. Apply today: https://lnkd.in/e8GArtha #Opentowork #hiring #leadership #softwareengineering #legal #biotechsales #biotech #biotechnology #newpositions

Our Chief Growth Officer, Nick Brown and Kristie Dolan, Senior VP and General Manager of Oncology and Pathology for Quest Diagnostics, were recently interviewed about the exciting ongoing #collaboration between PathAI and Quest Diagnostics and what it means for the future of #digitalpathology. https://lnkd.in/ggqy_q8g This strategic relationship marks a new era in digital pathology. PathAI will continue to support Quest through our cutting-edge AISightⓇ digital pathology image management system, enhancing the efficiency and quality of #pathology operations across the US. Our focus will remain on driving #innovation and advancing AI-powered solutions to improve patient outcomes and streamline healthcare delivery. Read more in the latest article to learn how our collaboration with Quest is set to transform the pathology landscape. #DigitalPathology #AI #Healthcare #HealthcareInnovation #QuestDiagnostics #Biotech #Biotechnology